Skip to main content

Validation of loop-mediated isothermal amplification for the detection of Loa loa infection in Chrysops spp in experimental and natural field conditions



The mass drug administration of ivermectin for onchocerciasis control has contributed to a significant drop in Loa loa microfilaria loads in humans that has, in turn, led to reduction of infection levels in Chrysops vectors. Accurate parasite detection is essential for assessing loiasis transmission as it provides a potential alternative or indirect strategy for addressing the problem of co-endemic loiasis and lymphatic filariasis through the Onchocerciasis Elimination Programme and it further reflects the true magnitude of the loiasis problem as excess human mortality has been reported to be associated with the disease. Although microscopy is the gold standard for detecting the infection, the sensitivity of this method is compromised when the intensity of infection is low. The loop-mediated isothermal amplification (LAMP) assay of parasite DNA is an alternative method for detecting infection which offers operational simplicity, rapidity and versatility of visual readout options. The aim of this study was to validate the Loa loa LAMP assay for the detection of infected Chrysops spp. under experimental and natural field conditions.


Two sets of 18 flies were fed on volunteers with either a low (< 10 mf/ml) or high (> 30,000mf/ml) microfilarial load. The fed flies were maintained under laboratory conditions for 14 days and then analysed using LAMP for the detection of L. loa infection. In addition, a total of 9270 flies were collected from the north-west, east, and south-west regions (SW 1 and 2) of Cameroon using sweep nets and subjected to microscopy (7841 flies) and LAMP (1291 flies plus 138 nulliparous flies) analyses.


The LAMP assay successfully detected parasites in Chrysops fed on volunteers with both low and high microfilariaemic loads. Field validation and surveillance studies revealed LAMP-based infection rates ranging from 0.5 to 31.6%, with the lowest levels in SW 2 and the highest infection rates in SW 1. The LAMP assay detected significantly higher infection rates than microscopy in four of the five study sites.


This study demonstrated the potential of LAMP as a simple surveillance tool. It was found to be more sensitive than microscopy for the detection of experimental and natural L. loa infections in Chrysops vectors.


Loa loa, also known as the African eye worm, is a parasitic nematode which causes the neglected tropical disease loiasis. The parasite is transmitted to humans by two main species of tabanid flies of genus Chrysops, namely Chrysops silacea and C. dimidiate [1, 2]. Infection with this filarial nematode is restricted to the rainforest and some savannah areas of Western and Central Africa [3, 4], where an estimated 3 to 13 million people live with the parasite [5]. The burden of disease is highest in Angola, Cameroon, Republic of Congo, Democratic Republic of Congo, Central African Republic, Gabon and Nigeria [4]. Typical reported symptoms include Calabar swellings (transient, localized angioedema) and sub-conjuctival migration of the adult L. loa worm [6]. Despite these manifestations, L. loa infection has largely been neglected as a public health problem in Africa. Loa loa-infected individuals are treated with diethylcarbamazine, which is active against adults and microfilaria(e) (mf) [7] followed by albendazole to eliminate residual mf [8]. The occurrence of Calabar swelling and/or a history of eye worm are used as an indication of infection; however, for definitive diagnosis, detection of mf is required [9]. The monitoring of infection rates in vectors is a rapid and sensitive indicator of the change in community microfilarial load resulting from the distribution of ivermectin, a broad-spectrum anti-parasitic agent [10]. Furthermore, from logistical and ethical perspectives, monitoring infections in the vector offers some advantages over repeated blood examinations of the human population [11]. Specifically, accurate detection of the infection rates in vector populations is essential for assessing transmission, deciding when drug treatments may be stopped and monitoring recrudescence [12]. Several studies have documented reduction of the prevalence and intensity of loiasis in the human population after treatment with ivermectin [13,14,15,16]; however, little information is available on the infection rate of the vectors after chemotherapy. In a well-organised control programme, ivermectin would deplete microfilariae in the host, and Chrysops flies would tend to take up lower numbers of mf in their blood meals. Thus, accurate diagnostic tests are needed for careful detection of filarial infections in areas where mass drug administration is underway. Currently, the only diagnostic method routinely used for entomological evaluation after chemotherapy is fly dissection using microscopy. While microscopy is a valuable technique, morphological interpretation can be subjective and requires substantial expertise and great effort when large numbers of samples are being processed. In practice, this is not easy for large-scale surveys.

Alternatively, PCR-based molecular assays have been developed that are specific for the detection of L. loa mf in blood samples [17,18,19], which could be optimized for L. loa detection in Chrysops vectors. However, such assays are time consuming and not generally suitable for use in endemic areas because of the need for highly skilled personnel and high-precision thermocyclers [5]. In addition, the targets of these molecular assays are either present in the genome at a low copy number, which can impact sensitivity, or are not species-specific [20].

Loop-mediated isothermal amplification (LAMP) has emerged as a potential alternative to PCR amplification techniques. LAMP amplifies a target DNA with high specificity, efficiency and rapidity under isothermal conditions [21]. A LAMP assay which targets a highly repetitive DNA target, repeat family 4 (RF4), in L. loa has recently been developed [20]. Although this assay represents a major step forward in terms of the search for new diagnostic tools, it has been developed under experimental conditions and, therefore, there is a need to evaluate its performance in the field. The aim of the study reported here was, therefore, to validate the RF4-based LAMP assay as an alternative to dissection for L. loa detection in Chrysops under experimental and natural field conditions.


Study sites

Flies were collected from four sites undergoing mass drug administration (MDA) with ivermectin and from a non-MDA site (Batouri Health District) in eastern Cameroon (Fig. 1). The MDA sites included two Community-Directed Treatment with Ivermectin (CDTI) Project sites in the south-west part of Cameroon (SW1 and SW2) and sites in the east (Messamena Health District) and north-west (NW) regions of the country (NWA Health District). The CDTI SW1 site operates within the Mungo and Meme drainage basins and SW2 operates in the Manyu drainage basin [22]. Each of these sites has a different ivermectin MDA treatment profile. SW1 (Kumba Health District) and SW2 (Mamfe Health District) are situated in areas of mild L. loa endemicity and have been under CDTI for more than a decade (12–14 years) at the time of this study [23], whereas the eastern and north-western project sites are situated in areas of high L. loa endemicity and have been under CDTI for 10 and 9 years, respectively, prior to the study [24, 25]. A CDTI-naïve site (Batouri Health District) in the eastern region of the country was also surveyed. This site is known to be L. loa hyper-endemic from a previous study [26].

Fig. 1

Study sites with Chrysops fly collection points shown

The climate in the southwest and northwest regions is tropical with two seasons: one wet season of about 9 months, lasting from March to November, and a short dry season, lasting from mid-November to mid-March. The mean annual rainfall in these areas varies from 2500 to 4000 mm. Ambient temperature ranges from 20 ℃ to 40 ℃ depending on the season. The climate in the eastern region is a type A wet equatorial climate [27], with an annual rainfall of 1500–2000 mm and an average temperature of about 24 ℃. This region has four seasons: a long dry season from December to May, a light wet season from May to June, a short dry season from July to October and a heavy wet season from October to November [25].

Study design

As the aim of the study was to evaluate the performance and suitability of the LAMP assay as a surveillance tool, there were two phases to the study: one involving the use of experimentally infected flies to determine sensitivity and a field phase using wild-caught insects.

Collection and laboratory maintenance of experimentally fed Chrysops flies

Chrysops flies were allowed to take blood from consenting microfilaraemic volunteers, then caught using the human landing method using 50-ml Falcon tubes (Corning Inc., Corning, NY, USA). Each tube was prepared to provide suitable conditions for the survival and transport of a single fly, as described previously by Wanji et al. [28]. For the experimental infections, two batches of 18 flies were each fed on either a microfilaraemic volunteer with a low microfilarial load (< 10 mf/ml blood) (Lot 1) or with a high microfilarial load (> 30,000 mf/ml blood) (Lot 2). Once back in the laboratory, the Chrysops flies were maintained for up to 14 days to monitor larval development (time for the mf to develop to the third larval stage [L3; infective stage]) in the insectarium. Within this period, the flies were fed daily with a sterile 15% sucrose solution. The temperature of the insectarium was maintained between 23–28 °C and the relative humidity between 79–80 %, as described by Tendongfor et al. [29]. Two flies from each lot were frozen at − 20 ℃ on day 0 (< 7 h post infection [PI]) and on days 1, 4, 6, 7, 10, 11, 12 and 14 PI. At the end of the experiment, the flies were separated into the head, thorax and abdomen, and DNA was extracted from each body part and subjected to the RF4-based LAMP assay for detection of infection.

Field collection of wild Chrysops flies

Insect collections were conducted essentially as described by Duke [30], between 7 a.m. and 6 p.m. from August to October 2014 for a period of 5 days per community. Five trained collectors, dressed in thick clothing that completely covered their body to avoid being bitten by the flies, were stationed near a wood fire. Blood-seeking female flies attracted by the smoke were caught using sweep nets during their attempts to take a blood meal at the different study sites. The number of flies caught per hour was recorded. At the end of each collection session, wild-caught flies were then randomly separated into three groups. The first group served as a control group, as flies from this group were dissected to check for parity; of these 138 nulliparous flies were retained to be further evaluated using the RF4-based LAMP assay. This group served to ascertain the specificity of the assay in the detection of L. loa parasite and thereby removed any issues of confounding factors arising from the flies. The remaining two groups were evaluated using either conventional dissection and microscopy or stored in 80% alcohol for DNA extraction followed by LAMP to detect L. loa infection.

Dissection of wild Chrysops flies

Wild Chrysops were transported in a cold box to the field laboratory and dissected immediately after collection. After a slight jab using a needle tip that knocked out the flies, the flies were dissected in physiological saline (0.9% NaCl) under a dissecting microscope. The head, thorax and abdomen of each fly was separated and placed on slides containing a drop of dissecting medium. The abdomen was teased gently to pull out the ovarioles and spread out to determine the presence (parous) or absence (nulliparous) of follicular relics on the pedicel, as described by Duke [31]. Parous flies were further dissected for the presence or absence of L. loa larvae. Larvae were classified into the sausage (L1) stage, larval stage 2 (L2) and L3 following the methods of Duke [32] and Orihel [33]. The infection rates were generated as described by Duke [34] and Noireau et al. [35].

Purification of DNA from Chrysops flies

DNA was extracted using the Zymo Research Genomic DNA Tissue™ MiniPrep Kit (Zymo Research, Irvine, CA, USA) following the manufacturer’s protocol. Briefly, Chrysops spp. were crushed individually with the help of sterile micro-pestles in Eppendorf tubes containing 95 μl of water, 95 μl of 2 × digestion buffer and 10 μl Proteinase K solution. The mixtures were incubated at 55 ℃ in a water bath for 1–3 h to denature the nucleases. An 700-μl aliquot of genomic lysis buffer was added to the samples, which were then were mixed thoroughly using a vortex machine followed by a centrifugation step at 10,000 g for 1 min to remove insoluble debris. The individual supernatants were carefully transferred to Zymo-spin columns in different collection tubes and then centrifuged at 10,000 g for 1 min. The columns were removed and inserted into 2-ml collection tubes, and 200 μl of DNA pre-wash buffer was added to the different spin columns in the new collection tubes followed by centrifugation at 10,000 g for 1 min. Genomic DNA wash buffer (400 μl) was added to the spin columns and centrifuged at 10,000 g for 1 min. The spin columns were later transferred into clean 1.5-ml Eppendorf tubes. DNA in the spin columns were reconstituted in 200 µl of elution buffer and incubated for 2–5 min at room temperature, followed by a centrifugation step at maximum speed for 30 s. Finally, the DNA was stored at − 20 ℃ until use.

LAMP assay to detect L. loa

The L. loa LAMP primers [20] targeting the RF4 that were used for the colorimetric assay were synthesized and purified by high-performance liquid chromatography (Integrated DNA Technologies, Coralville, IA, USA). The primers used and their sequences (5′–3′) were: F3 (TCTTTCYTTTTATCGAGTCGTT); FIP (CGACGTCTTCACAAGGTAAGCC-GTTTAGCCTTGAGTTAGGATC); BIP (GGACACAGAGTAAAATTTACCGCT-CGATTTYCTACTCGTTATTCTTCAA; B3 (AACAGCYTTTGACTCACG); LF (TTAATTAAAGTTCTGCT) and LB (TACAGAGTTGATCAGTAGG).

The LAMP reactions contained 1.6 μM of each of primers FIP and BIP, 0.2 μM of each of primers F3 and B3, 0.4 μM of each of primers LF and LB, 12.5 μl of WarmStart Colorimetric LAMP 2× Master Mix (New England Biolabs Inc., Ipswitch, MA, USA) with 2 μl of template DNA or molecular biology grade H20 for non-template controls (NTCs), in a total volume of 25  μl. Reactions were incubated at 61 ℃ for up to 40 min in a GeneAmp® PCR System 9700 Thermal Cycler (Applied Biosystems, Foster City, CA, USA). A detailed description of the method and reaction setup can be found in Additional file 1: Table S1). Samples were considered positive for L. loa DNA if an obvious colour change from pink to yellow was observed, while negative samples remained pink (Fig. 2). NTCs were included in each LAMP reaction; the controls never showed signs of amplification.

Fig. 2

Detection of DNA amplification in the loop-mediated isothermal amplification (LAMP) assay by a change in color. The Loa loa primer set was used to amplify genomic L. loa DNA using the colorimetric master mix containing phenol red dye and Bst 2.0 WarmStart DNA Polymerase (New England Biolabs Inc). Before amplification (T0), reactions are pink. Samples turn yellow if positive for presence of L. loa DNA or remain pink if negative, as shown in photographs after a 40-min (T40) amplification. NTC non-template control, PC positive control

Due to the high sensitivity of LAMP, precautions were taken to prevent cross-contamination in every experiment. DNA contamination and carry-over of amplified products were prevented by using filter tips at all times, cleaning all work surfaces with a 10% bleach solution before and after each session of work, performing each step of the analysis in separate work areas and minimizing manipulation of the reaction tubes. All tubes are tightly closed and never opened after amplification to avoid contaminating the work area.

Data processing and analysis

Data were collected and compiled on record sheets and later entered into a template designed in Microsoft Excel 2010 (Microsoft Corp., Redmond, WA, USA). The data were then exported to the SPSS version 20 software package (IBM Corp., Armonk, NY, USA) for subsequent analysis. Contingency tables were used to express the relationship between variables. Fischer’s exact test was used to compare proportions, and all statistical tests were performed at a 5% significance level. The infection rate was determined as the proportion of infected flies to the total number of flies dissected.


Detection of L. loa infection in experimentally infected Chrysops flies using LAMP technology

Equal numbers (n = 18) of flies which were fed on a volunteer with either a low or high microfilarial load were analysed using the colorimetric RF4-based LAMP assay. Positive and negative control samples containing either genomic DNA from L. loa or molecular biology grade H20, respectively, were included in each assay (Fig. 2). According to the RF4-based LAMP assay, of the 18 flies allowed to engorge on a volunteer with a low parasitaemia level, 16 were positive (88.9%), and of those flies that fed on a volunteer with a high parasitaemia level, 17 (94.4%) scored positive (Table 1).

Table 1 Loa loa infection rates in experimentally infected Chrysops determined by the loop-mediated isothermal amplification assay

Comparing the infection status of the two groups of experimentally fed Chrysops with respect to different parts of the flies (head, thorax and abdomen) over time, the detection of infection in flies that ingested low mf numbers was limited to the abdomen up to 7 days PI, whereas from day 10 PI onwards, parasites were detected in the head and thorax as well as abdomen (Fig. 3). However, for flies fed on a volunteer with a high parasitaemia level, infection was detected in all the parts of the flies at all-time points examined (Fig. 4).

Fig. 3

Infection status of flies fed on a microfilaraemic volunteer with a low parasitaemia level. Numbers 1–14 in boxes at top of figure indicate number of days PI. H, T, A Head, thorax and abdomen of experimentally fed Chrysops

Fig. 4

Infection status of flies fed on a microfilaraemic volunteer with a high parasitaemia level. Numbers 1–14 in boxes at top of figure indicate number of days PI

Detection of L. loa infection in nulliparous Chrysops and Mansonella perstans samples using the LAMP assay

We tested DNA from Mansonella perstans and a total of 138 nulliparous Chrysops flies as negative controls to confirm the specificity of the LAMP assay. No amplification was ever observed in these controls (Fig. 5a, b).

Fig. 5

Absence of L. loa infection in nulliparous Chrysops and Mansonella perstans samples. a Nulliparous samples, b M. perstans (M.P.) samples compared to NTC and positive control (PC). Before amplification (T0), reaction solutions are pink. Samples remained pink after the assay, indicating negativity, as shown on the photographs after a 40-min amplification (T40). Nulliparous Chrysops are flies that have never taken a blood meal; as such, samples should remain negative in the assay

Detection of L. loa infection in wild-caught Chrysops using the microscopy method

A total of 7841 wild-caught Chrysops from the five study sites were dissected and examined for the presence of L. loa infection using microscopy. An overview of the different parasite stages obtained from the flies caught in the different health districts is given in Additional file 2: Table S2. Of these 7841 flies, 257 (3.3%) were found to be infected (Table 2). The highest infection rate, 4.4% (103/2365), was recorded in the non-MDA site (Batouri Health District), followed by 3.5% (17/485) and 3.3% (61/1861) in the NWA and Messamena health districts, respectively. In comparison, 66/2318 (2.8%) and 10/812 (1.2%) of wild-caught flies were L. loa positive in the SW 1 and SW 2 CDTI project sites, respectively. Globally, a significant difference (P < 0.001) in infection rate was observed between the study sites.

Table 2 Natural infection rates of Chrysops in the five study sites determined by microscopy and the loop-mediated isothermal amplification assay

Detection of L. loa Infection in wild-caught Chrysops using the LAMP assay

The LAMP assay was performed on DNA extracted from 1291 wild-caught Chrysops flies. Of the 1291 flies analysed, 304 were positive, giving an overall infection rate of 23.5% (Table 2). In the non-MDA site, 26.2% (48/183) flies were positive. Similar levels of infection were observed in the north-west (30.2%, 88/291) and SW 1 (31.6%, 138/434) sites. In the eastern MDA site (Messamena Health District), 16.5% (30/183) samples were positive whereas only 0.5% (1/200) of flies scored positive in the SW 2 site.

Comparison of detection rates of L. loa in wild-caught chrysops using microscopy and the LAMP assay in various study sites

Overall, the RF4-based colorimetric LAMP assay was found to be significantly more sensitive than microscopy in detecting L. loa infection in wild-caught Chrysops from the various study sites (P < 0.001) (Table 2). An exception was found in the SW 2 CDTI project site where there was no significant difference between the infection rate detected by the two methods (P = 0.105).


In Western and Central Africa, co-infection with loiasis and onchocerciasis is a common occurrence [36]. Consequently, entomological evaluation of L. loa in the vectors would assist in the development of mathematical models of loiasis transmission and control. While this may not be a solution to reducing the risk of severe adverse effects in the short term, it would provide long-term benefits in terms of the construction of a mathematical model reflecting the epidemiological features of L. loa both in the vector and human host, consequently enabling an assessment of the indirect impact of interventions intended to control and eliminate onchocerciasis or lymphatic filariasis and in evaluating the need for further interventions specifically targeting loiasis [37]. Thus, surveying Chrysops infection rates in areas where Onchocerca volvulus and L. Loa are co-endemic is a rapid and an important indicator of transmission that to date depends on microscopic examination. However, the detection of L. loa larvae in Chrysops can be a challenge when parasite densities are low, which is often the case when MDA programmes are ongoing, primarily due to the flies tending to take up lower numbers of mf, thus making microscopic detection difficult. Two studies [5, 38] have described the use of LAMP for L. loa using the PCR targets LL3M9 and LLMF72. However, these are not necessarily ideal targets for this platform as LL3M9 contains multiple copies of a simple 6-bp repeat that is conserved in nematodes, and LLMF72 is a single-copy gene that may affect specificity and sensitivity of the assay [20]. Genome filtering for new DNA biomarkers of L. loa infection particularly suited to LAMP has resulted in the discovery of several candidates. Of these, RF4, which is highly abundant in the parasite genome, was used to develop a highly sensitive and specific LAMP assay which can detect the DNA equivalent of approximately  1/1600th of a mf [20]. The main goal of the present study was to evaluate the performance of this promising method to detect L. loa infection in Chrysops spp. using experimentally infected flies and wild-caught flies in natural field conditions.

When LAMP was used to detect L. loa in experimentally infected Chrysops, the overall infection rate of flies fed on a volunteer with a high parasitaemia level (> 30,000 mf/ml) was 94.4% (17/18 flies) while those fed on a volunteer with a low parasitaemia level (< 10 mf/ml of blood) was 88.9% (16/18). The specificity of the assay was demonstrated using 138 nulliparous flies, none of which scored positive.

In insect vectors, the presence of a peritrophic membrane (PM), which is an extracellular envelope that lines the digestive tract of most insects after blood is ingested, serves as a barrier to infection by pathogens [39, 40] present in blood. It is considered to be the main factor limiting the success rate of microfilarial development following blood infections [41]. Immediately after blood ingestion, the epithelial cells of the posterior midgut secrete the PM, which then envelops the blood. Some mf penetrate the PM before it completely hardens, but the majority die inside the PM. Following ingestion of L. loa mf, a period of 7–14 days is required for the parasites to develop into L3 (infective) larvae [42,43,44,45]. Development has been reported to take place in the fat body of the head, thorax and—principally—the abdomen of the fly [44, 45]. Interestingly, in Chrysops experimentally infected with a low level of infection, LAMP detected parasites as early as day 1 and up to day 7 PI solely in the abdomen. From day 10 onwards, parasites were found throughout the flies. Based on these results, it would thus appear that the infective forms, having migrated to the head, do not remain there until they are offered an opportunity of escaping but that they are capable of freely migrating back to the thorax and the abdomen [44, 46]. In contrast, infection was detected in the head, thorax and abdomen on days 1–14 PI when flies fed on an individual with a high parasitaemia level. The ability of the RF4-based LAMP assay to successfully detect as few as < 10 mf/ml and any developmental stage of the parasite that may be present in the insect hosts suggests the suitability of this method for identification of Chrysops with extremely low levels of infection that may be missed using the conventional microscopy method. A high level of sensitivity is particularly important in areas where prolonged administration of ivermectin has led to the drastic reduction of parasite in the host [47].

Microscopy and LAMP assays were used to identify L. loa-infected wild-caught Chrysops from the different study sites. In general, significantly higher rates of infection were detected using LAMP. The east MDA, east non-MDA, SW 1, and north-west sites recorded the highest infection rates with LAMP (16.4, 26.2, 31.6 and 30.2, respectively) while SW 2 CDTI project site recorded the lowest infection rate of 0.5%.

At the SW 1 CDTI project site, infection rates remained high despite more than a decade of mass treatment with ivermectin. These startling and unsatisfactory observations could be attributed to the persistence of a permanent parasite reservoir. A study by Wanji et al. [22] showed a tepid attitude towards ivermectin intake in the study area. These low adherences in meso- and hyper endemic areas may constitute a permanent transmission of infections in such areas and could be attributed to fear of side effects, as reported by many authors [48, 49]. This finding also tends to confirm findings by Kouam et al. [50] who attributed this stability to the level of exposure of L. loa that has not changed after >  10 years of treatment.

LAMP has previously been shown to be more efficient than PCR in detecting O. volvulus DNA recovered from black fly material [51]. This better efficacy of the LAMP assy is likely due to insect material containing various biological substances that inhibit the polymerases used in PCR. Indeed, the Bst DNA polymerase used in LAMP is more tolerant to PCR inhibitors commonly found in clinical specimens and insects [51,52,53]. LAMP has also been shown to detect a single mf of Dirofilaria immitis in mosquitoes following feeding on infected canine blood [54]. LAMP has other distinct advantages over PCR, including its operational simplicity and isothermal nature. In PCR, thermal cycling is required to denature the template, anneal primers and extend the amplicon. LAMP employs Bst DNA polymerase, which provides both strand displacement and target amplification at a single temperature in a simple heat block or water bath at 60–65 ℃ [21] or other portable device with a stable heat source [55]. In addition, LAMP assays have been reported to be significantly cheaper to run than PCR [56]. The rapidity and versatility in readout options also makes the LAMP assay a particularly appealing technology. In its simplest form, as demonstrated here, a clear color change can be easily used in field conditions to indicate amplification of L. loa target DNA in infected Chrysops. In this study, the colorimetric L. loa LAMP assay was used as a rapid qualitative test. However, this LAMP assay can be easily applied as a quantitative approach by adding a fluorescent dye to the colorimetric master mix and incorporating a standard curve to monitor amplification of samples and controls in a real-time PCR machine, as has been described for the Wuchereria bancrofti LDR LAMP assay [55]. Alternatively, the change in optical density due to the change of colour from pink to yellow can be monitored using a spectrophotometer, as described by Thi et al. [57].


This study was designed to validate the LAMP assay for detection of L. loa infection rates in Chrysops spp in experimental and natural field conditions. The RF4-based LAMP assay as described herein successfully detected L. loa parasites in Chrysops allowed to feed on individuals with either a low and high parasitaemia level and could also be used to detect infection in wild-caught flies from the different study sites. This molecular assay was considerably more sensitive than the gold standard, microscopy, as it detected a greater number of infected Chrysops in four of the five study sites. The assay is also highly specific as no amplification was observed using nulliparous flies or M. perstans DNA. The remarkable sensitivity and specificity of the RF4-based LAMP assay and validation of its performance in the field to detect infected Chrysops indicate its usefulness as a surveillance tool in global health programmes aimed at achieving elimination of filarial infections.

Availability of data and materials

All data generated or analysed during this study are included within the paper and/or Additional files 1, 2.



Backward inner primer


Forward inner primer


Loop-mediated isothermal amplification

L1, L2, L3:

Larval stages one, two, three (infective stage), respectively


Mass drug administration




Post infection


Repeat Family 4


  1. 1.

    Hawking F. The distribution of human filariasis throughout the world Part III. Africa. Trop Dis Bull. 1977;74(8):649–79.

    CAS  PubMed  Google Scholar 

  2. 2.

    Ratmanov P, Mediannikov O, Raoult D. Vectorborne diseases in West Africa: geographic distribution and geospatial characteristics. Trans R Soc Trop Med Hyg. 2013;107(5):273–84.

    PubMed  Article  Google Scholar 

  3. 3.

    Kelly-Hope LA, Bockarie MJ, Molyneux DH. Loa loa ecology in Central Africa: role of the Congo River System. PLoS Negl Trop Dis. 2012;6(6):e1605.

    PubMed  PubMed Central  Article  Google Scholar 

  4. 4.

    Zouré HGM, Wanji S, Noma M, Amazigo UV, Diggle PJ, Tekle AH et al. The geographic distribution of Loa loa in Africa: results of large-scale implementation of the rapid assessment procedure for loiasis (RAPLOA). PLoS Negl Trop Dis. 2011;5(6):e1210.

    PubMed  PubMed Central  Article  Google Scholar 

  5. 5.

    Fernández-Soto P, Mvoulouga PO, Akue JP, Abán JL, Santiago BV, Sánchez MC, et al. Development of a highly sensitive loop-mediated isothermal amplification (LAMP) method for the detection of Loa loa. PLoS ONE. 2014;9(4):e94664.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  6. 6.

    Akue JP, Nkoghe D, Padilla C, Moussavou G, Moukana H, Mbou RA, et al. Epidemiology of concomitant infection due to Loa loa and Mansonella perstans in Gabon. PLoS Negl Trop Dis. 2011;5(10):e1329.

    PubMed  PubMed Central  Article  Google Scholar 

  7. 7.

    Klion AD, Ottesen EA, Nutman TB. Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis. 1994;169(3):604–10.

    CAS  PubMed  Article  Google Scholar 

  8. 8.

    Klion AD, Massougbodji A, Horton J, Ekoué S, Lanmasso T, Ahouissou N-L, et al. Albendazole in human loiasis: results of a double-blind, Placebo-Controlled Trial. J Infect Dis. 1993;168(1):202–6.

    CAS  PubMed  Article  Google Scholar 

  9. 9.

    World Health Organization. Certification of elimination of human onchocerciasis: criteria and procedures. Geneva: World Health Organization; 2001.

    Google Scholar 

  10. 10.

    World Health Organization. Guidelines for stopping mass drug administration and verifying elimination of human onchocerciasis: criteria and procedures. Geneva: World Health Organization; 2016.

    Google Scholar 

  11. 11.

    Boatin BA, Toe L, Alley ES, Dembele N, Weiss N. Diagnostics in onchocerciasis: future challenges. Ann Trop Med Parasitol. 1998;92(3):41–5.

    Article  Google Scholar 

  12. 12.

    Okorie PN, De Souza DK. Prospects, drawbacks and future needs of xenomonitoring for the endpoint evaluation of lymphatic filariasis elimination programs in Africa. Trans R Soc Trop Med Hyg. 2016;110(2):90–7.

    PubMed  Article  Google Scholar 

  13. 13.

    Adeoye GO, Akinsanya B, Otubanjo AO, Ibidapo CA, Atalabi T, Okwuzu J, et al. Prevalences of loiasis in Ondo state, Nigeria, as evaluated by the rapid assessment procedure for loiasis (RAPLOA). Ann Trop Med Parasitol. 2008;102(3):215–27.

    CAS  PubMed  Article  Google Scholar 

  14. 14.

    Duong TH, Kombila M, Ferrer A, Bureau P, Gaxotte P, Richard-Lenoble D. Reduced Loa loa microfilaria count ten to twelve months after a single dose of ivermectin. Trans R Soc Trop Med Hyg. 1997;91(5):592–3.

    CAS  PubMed  Article  Google Scholar 

  15. 15.

    Gardon J, Kamgno J, Folefack G, Gardon-Wendel N, Bouchité B, Boussinesq M. Marked decrease in Loa loa microfilaraemia six and twelve months after a single dose of ivermectin. Trans R Soc Trop Med Hyg. 1997;91(5):593–4.

    CAS  PubMed  Article  Google Scholar 

  16. 16.

    Wanji S, Chounna Ndongmo WP, Fombad FF, Kengne-Ouafo JA, Njouendou AJ, Longang Tchounkeu YF, et al. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa. PLoS Negl Trop Dis. 2018;12(9):e0006750.

    PubMed  PubMed Central  Article  Google Scholar 

  17. 17.

    Fink DL, Kamgno J, Nutman TB. Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis. 2011;5(8):e1299.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  18. 18.

    Tang T-HT, Lopez-Velez R, Lanza M, Shelley AJ, Rubio JM, Luz SLB. Nested PCR to detect and distinguish the sympatric filarial species Onchocerca volvulus, Mansonella ozzardi and Mansonella perstans in the Amazon Region. Mem Inst Oswaldo Cruz. 2010;105(6):823–828.

  19. 19.

    Touré FS, Kassambara L, Williams T, Millet P, Bain O, Georges AJ, et al. Human occult loiasis: improvement in diagnostic sensitivity by the use of a nested polymerase chain reaction. Am J Trop Med Hyg. 1998;59(1):144–9.

    PubMed  Article  Google Scholar 

  20. 20.

    Poole CB, Ettwiller L, Tanner NA, Evans TC, Wanji S, Carlow CKS. Genome filtering for new DNA Biomarkers of Loa loa Infection suitable for loop-mediated isothermal amplification. PLoS ONE. 2015;10(9):e0139286.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  21. 21.

    Notomi T. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):63e–63.

    Article  Google Scholar 

  22. 22.

    Wanji S, Amvongo-Adjia N, Koudou B, Njouendou AJ, Chounna Ndongmo PW, Kengne-Ouafo JA, et al. Cross-reactivity of filariais ICT cards in areas of contrasting endemicity of Loa loa and Mansonella perstans in Cameroon: implications for shrinking of the lymphatic filariasis map in the central african region. PLoS Negl Trop Dis. 2015;9(11):e0004184.

    PubMed  PubMed Central  Article  Google Scholar 

  23. 23.

    Esum M, Wanji S, Tendongfor N, Enyong P. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin. Trans R Soc Trop Med Hyg. 2001;95(6):673–6.

    CAS  PubMed  Article  Google Scholar 

  24. 24.

    Wanji S, Tendongfor N, Esum M, Atanga SN, Enyong P. Heterogeneity in the prevalence and intensity of loiasis in five contrasting bioecological zones in Cameroon. Trans R Soc Trop Med Hyg. 2003;97(2):182–7.

    Article  Google Scholar 

  25. 25.

    Takougang I, Meli J, Lamlenn S, Tatah PN, Ntep M. Loiasis—a neglected and under-estimated affliction: endemicity, morbidity and perceptions in eastern Cameroon. Ann Trop Med Parasitol. 2007;101(2):151–60.

    CAS  PubMed  Article  Google Scholar 

  26. 26.

    Takougang I, Meremikwu M, Wandji S, Yenshu EV, Aripko B, Lamlenn SB, et al. Rapid assessment method for prevalence and intensity of Loa loa infection. Bull World Health Organ. 2002;80(11):852–8.

    PubMed  PubMed Central  Google Scholar 

  27. 27.

    Mphoweh JN, Futonge NK. Climate and relief of Cameroon. Accessed 14 May 2020.

  28. 28.

    Wanji S, Tendongfor N, Esum ME, Enyong P. Chrysops silacea biting densities and transmission potential in an endemic area of human loiasis in South-west Cameroon. Trop Med Int Health. 2002;7(4):371–7.

    PubMed  Article  Google Scholar 

  29. 29.

    Tendongfor N, Wanji S, Ngwa JC, Esum ME, Specht S, Enyong P, et al. The human parasite Loa loa in cytokine and cytokine receptor gene knock out BALB/c mice: survival, development and localization. Parasit Vectors. 2012;5(1):43.

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  30. 30.

    Duke BOL. Studies on the biting habits of Chrysops. Ann Trop Med Parasitol. 1955;49(3):260–72.

    CAS  PubMed  Article  Google Scholar 

  31. 31.

    Duke BO. Studies on the biting habits of Chrysops. VII. The biting-cycles of nulliparous and parous C. silacea and C. dimidiata (bombe form). Ann Trop Med Parasitol. 1960;54:147–155.

  32. 32.

    Duke BOL. Studies on the factors influencing the transmission of onchocerciasis. IV—The biting cycle, infective biting density and transmission potential of ‘forest’ Simulium damnosum. Ann Trop Med Parasitol. 1958;52(1):24–35.

    CAS  PubMed  Article  Google Scholar 

  33. 33.

    Orihel TC, Lowrie RC. Loa Loa: Development to the infective stage in an American deerfly, Chrysops Atlanticus. Am J Trop Med Hyg. 1975;24(4):610–5.

    CAS  PubMed  Article  Google Scholar 

  34. 34.

    Duke BOL. Studies on factors influencing the transmission of onchocerciasis. Ann Trop Med Parasitol. 1968;62(1):95–106.

    CAS  PubMed  Article  Google Scholar 

  35. 35.

    Noireau F, Sinda D, Itoua A, Nzoulani A. Transmission indices of Loa loa in the Chaillu Mountains. Congo Am J Trop Med Hyg. 1990;43(3):282–8.

    CAS  PubMed  Article  Google Scholar 

  36. 36.

    Kelly-Hope LA, Cano J, Stanton MC, Bockarie MJ, Molyneux DH. Innovative tools for assessing risks for severe adverse events in areas of overlapping Loa loa and other filarial distributions: the application of micro-stratification mapping. Parasites Vectors. 2014;7(1):307.

    PubMed  PubMed Central  Article  Google Scholar 

  37. 37.

    Whittaker C, Walker M, Pion SDS, Chesnais CB, Boussinesq M, Basáñez MG. The population biology and transmission dynamics of Loa loa. Trends Parasitol. 2018;34:4.

    Article  Google Scholar 

  38. 38.

    Drame PM, Fink DL, Kamgno J, Herrick JA, Nutman TB. Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection. J Clin Microbiol. 2014;52(6):2071–7.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  39. 39.

    Lehane MJ. Peritrophic matrix structure and function. Annu Rev Entomol. 1997;42(1):525–50.

    CAS  PubMed  Article  Google Scholar 

  40. 40.

    Terra WR. The origin and functions of the insect peritrophic membrane and peritrophic gel. Arch Insect Biochem Physiol. 2001;47(2):47–61.

    CAS  PubMed  Article  Google Scholar 

  41. 41.

    Eichner M, Renz A, Wahl G, Enyong P. Development of Onchocerca volvulus microfilariae injected into Simulium species from Cameroon. Med Vet Entomol. 1991;5(3):293–8.

    CAS  PubMed  Article  Google Scholar 

  42. 42.

    Connal A, Connal SLM. The development of Loa Loa (Guyot) in Chrysops Silacea (Austen) and in Chrysops Dimidiata (van der Wulp). Trans R Soc Trop Med Hyg. 1922;16(1–2):64–89.

    Article  Google Scholar 

  43. 43.

    Kershaw WE, Duke BOL. Studies on the intake of microfilariae by their insect vectors, their survival, and their effect on the survival of their vectors. Ann Trop Med Parasitol. 1954;48(3):340–4.

    CAS  PubMed  Article  Google Scholar 

  44. 44.

    Lavoipierre MMJ. Studies on the host-parasite relationships of filarial nematodes and their arthropod hosts. Ann Trop Med Parasitol. 1958;52(1):103–21.

    CAS  PubMed  Article  Google Scholar 

  45. 45.

    Williams P. Studies on Ethiopian Chrysops as possible vectors of loiasis. Ann Trop Med Parasitol. 1960;54(4):439–59.

    CAS  PubMed  Article  Google Scholar 

  46. 46.

    Gordon RM, Crewe W. The deposition of the infective stage of Loa loa by Chrysops silacea, and the early stages of its migration to the deeper tissues of the mammalian host. Ann Trop Med Parasitol. 1953;47(1):74–85.

    CAS  PubMed  Article  Google Scholar 

  47. 47.

    Alhassan A, Osei-Atweneboana MY, Kyeremeh KF, Poole CB, Li Z, Tettevi E, et al. Comparison of a new visual isothermal nucleic acid amplification test with PCR and skin snip analysis for diagnosis of onchocerciasis in humans. Mol Biochem Parasitol. 2016;210(1–2):10–2.

    CAS  PubMed  Article  Google Scholar 

  48. 48.

    El-Setouhy M, Shannon WD, Abd Elaziz KM, Weil GJ, Helmy H, Farid HA, et al. The effect of compliance on the impact of mass drug administration for elimination of lymphatic filariasis in Egypt. Am J Trop Med Hyg. 2007;77(6):1069–73.

    PubMed  PubMed Central  Article  Google Scholar 

  49. 49.

    Hussain MA, Sitha AK, Swain S, Kadam S, Pati S. Mass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance. Infect Dis Poverty. 2014;3(1):31.

    PubMed  PubMed Central  Article  Google Scholar 

  50. 50.

    Kouam MK, Tchatchueng-Mbougua JB, Demanou M, Boussinesq M, Pion SDS, Kamgno J. Impact of repeated ivermectin treatments against onchocerciasis on the transmission of loiasis: an entomologic evaluation in central Cameroon. Parasites Vectors. 2013;6(1):283.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  51. 51.

    Alhassan A, Makepeace BL, LaCourse EJ, Osei-Atweneboana MY, Carlow CKS. A simple isothermal DNA amplification method to screen black flies for Onchocerca volvulus infection. PLoS ONE. 2014;9(10):e108927.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  52. 52.

    Poon LLM, Wong BWY, Ma EHT, Chan KH, Chow LMC, Abeyewickreme W, et al. Sensitive and inexpensive molecular test for falciparum malaria: detecting Plasmodium falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clin Chem. 2006;52(2):303–6.

    CAS  PubMed  Article  Google Scholar 

  53. 53.

    Kaneko H, Kawana T, Fukushima E, Suzutani T. Tolerance of loop-mediated isothermal amplification to a culture medium and biological substances. J Biochem Biophys Methods. 2007;70(3):499–501.

    CAS  PubMed  Article  Google Scholar 

  54. 54.

    Aonuma H, Yoshimura A, Perera N, Shinzawa N, Bando H, Oshiro S, et al. Loop-mediated isothermal amplification applied to filarial parasites detection in the mosquito vectors: Dirofilaria immitis as a study model. Parasit vectors. 2009;2(1):15.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  55. 55.

    Poole CB, Li Z, Alhassan A, Guelig D, Diesburg S, Tanner NA, et al. Colorimetric tests for diagnosis of filarial infection and vector surveillance using non-instrumented nucleic acid loop-mediated isothermal amplification (NINA-LAMP). PLoS ONE. 2017;12(2):e0169011.

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  56. 56.

    Takagi H, Itoh M, Kasai S, Yahathugoda TC, Weerasooriya MV, Kimura E. Development of loop-mediated isothermal amplification method for detecting Wuchereria bancrofti DNA in human blood and vector mosquitoes. Parasitol Int. 2011;60(4):493–7.

    CAS  PubMed  Article  Google Scholar 

  57. 57.

    Thi VLD, Herbst K, Boerner K, Meurer M, Kremer LP, Kirrmaier D, et al. A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples. Sci Transl Med. 2020;12(556):7075.

Download references


We are very grateful to the volunteers who after informed consent collected Chrysops flies fed and unfed. Many thanks to the Chief of the different health centers, District Medical officer and Chief of Bureau health, the Regional Delegates of Public Health for facilitating the work, and the Regional and National Coordinators of Filariasis control programme for their administrative assistance. CKSC and CBP gratefully acknowledge financial support from New England Biolabs USA. KD is supported by the Wellcome Trust ([grant number 201900/Z/16/Z) as part of his international intermediate Fellowship.


This study received no formal funding, but reagents and consumables used for its implementation were graciously donated by colleagues from the New England Biolabs (USA) and University of Bonn (Germany).

Author information




SW conceived the work and designed the protocol with assistance of CBP, AH, KP, RAA and GNA. GNA, RAA, MR performed the experimental section supervised by SW, KP, CKSC and CBP. GNA, RAA, TMN, AJN, AAB, FFF, PIE, MEE, SW and KD performed data curation and analysis. GNA, RAA and SW drafted the manuscript that was reviewed, edited and approved by all authors. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Samuel Wanji.

Ethics declarations

Ethics approval and consent to participate

The study protocol, as a work package attached to the following studies [16, 22], received ethical approval from the Cameroon National Ethics Committee (2019/10/1192/CE/CNERSH/SP). The objective of the study was explained to the trained collectors, and informed consent was obtained from all participants. Measures were taken to minimize the health risk of microfilaraemic volunteers, workers and neighbouring inhabitants as the flies were stored in properly closed tubes and kept in a standard insectarium with protective doors and windows. Furthermore, volunteers with low and high microfilariae in the blood were treated with albendazole after the catching session. They were also given antihistamine (dexamethasone) to prevent itches as a result of the bites.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1

: Table S1. Colorimetric LAMP Protocol for the detection of L. loa.

Additional file 2

: Table S2. The Different parasite stages found in the dissected Chrysops flies.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Amambo, G.N., Abong, R.A., Fombad, F.F. et al. Validation of loop-mediated isothermal amplification for the detection of Loa loa infection in Chrysops spp in experimental and natural field conditions. Parasites Vectors 14, 19 (2021).

Download citation


  • Loa loa
  • Chrysops
  • RF4-based LAMP
  • Microscopy
  • Ivermectin